To investigate safety issues related to use of haploidentical highly purified CD133+ hematopoietic cells in patients with SCID [clinicaltrials_resource:d0781a4f8f46dad56c290aa6b2045a39]

St. Jude Children's Research Hospital

To investigate safety issues related to use of haploidentical highly purified CD133+ hematopoietic cells in patients with SCID [clinicaltrials_resource:d0781a4f8f46dad56c290aa6b2045a39]

St. Jude Children's Research Hospital